Peter C. Brandt - Apr 27, 2025 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Apr 27, 2025
Transactions value $
$30,229
Form type
4
Date filed
5/7/2025, 08:45 PM
Previous filing
Dec 23, 2024
Next filing
May 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brandt Peter C. Director C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK /s/ Jason Minio, Attorney-in-Fact 2025-05-07 0001434099

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Options Exercise $15.1K +82K +15.84% $0.18 600K Apr 30, 2025 Direct
transaction INAB Common Stock Options Exercise $15.1K +82K +13.67% $0.18 682K Apr 30, 2025 Direct
holding INAB Common Stock 105K Apr 27, 2025 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Disposed to Issuer -82K -100% 0 Apr 27, 2025 Common Stock 82K $0.45 Direct F2, F3, F4
transaction INAB Series A Warrants (right to buy) Award +82K 82K Apr 27, 2025 Common Stock 82K $0.18 Direct F2, F3
transaction INAB Series A Warrants (right to buy) Options Exercise $0 -82K -100% $0.00 0 Apr 30, 2025 Common Stock 82K $0.18 Direct F3
transaction INAB Series B Warrants (right to buy) Disposed to Issuer -82K -100% 0 Apr 27, 2025 Common Stock 82K $1.50 Direct F3, F4, F5
transaction INAB Series B Warrants (right to buy) Award +82K 82K Apr 27, 2025 Common Stock 82K $0.18 Direct F3, F5
transaction INAB Series B Warrants (right to buy) Options Exercise $0 -82K -100% $0.00 0 Apr 30, 2025 Common Stock 82K $0.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
F2 The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.
F3 Fully vested and exercisable.
F4 The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
F5 The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.